NICOLE SCHEIDLER: Open Payments
NPI 1760082002 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 13 payments from 9 companies in 2025. Trend: 2023 $118 · 2024 $387 · 2025 $974
Food & beverage: $955Education: $19
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $171 |
| Insulet Corporation | 3 | $161 |
| Lilly USA, LLC | 2 | $135 |
| SANOFI-AVENTIS U.S. LLC | 1 | $125 |
| Novo Nordisk Inc | 1 | $121 |
| Boston Scientific Corporation | 1 | $112 |
| Exact Sciences Corporation | 1 | $89 |
| Gilead Sciences, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: INPEN SMART INSULIN DELIVERY SYSTEM, OMNIPOD, MOUNJARO, TZIELD, Wegovy, WATCHMAN FLX, The Cologuard Plus Collection Kit, JARDIANCE.
Industry payments across IN — which companies pay providers there.
